Related Experiment Video
Updated: Feb 24, 2026
Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Cerebral amyloid angiopathy as a cause of neurodegeneration
1Associate Professor of Neurology, University of Calgary, Health Sciences Centre, Calgary, Alberta, Canada.
Insights
Cerebral amyloid angiopathy (CAA) causes more complex brain injury than previously thought, leading to atrophy and cognitive decline. These findings suggest unique neurodegenerative pathways distinct from Alzheimer's disease.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Cerebral amyloid angiopathy (CAA) is primarily known for causing hemorrhagic strokes and transient neurological episodes in older adults.
- Recent research reveals a more complex pathophysiology of CAA, implicating diverse forms of brain injury beyond traditional stroke events.
Purpose of the Study:
- To explore the multifaceted nature of cerebral amyloid angiopathy (CAA) and its association with neurodegenerative processes.
- To investigate the link between CAA, remote brain atrophy, and progressive cognitive decline.
Main Methods:
- Review of recent scientific literature on cerebral amyloid angiopathy (CAA) and its pathological consequences.
- Analysis of studies linking CAA to brain atrophy and cognitive impairment, differentiating from Alzheimer's disease.
Main Results:
- CAA is associated with brain atrophy in regions distant from hematomas and increased risk of cognitive decline, even without new strokes.
- The patterns of cortical thinning and cognitive deficits in CAA show distinctions from Alzheimer's disease, suggesting specific neurodegenerative mechanisms.
- CAA-related cerebral ischemia emerges as a potential key factor in brain injury, disconnection, and cognitive impairment.
Conclusions:
- Cerebral amyloid angiopathy (CAA) contributes to neurodegeneration through mechanisms distinct from Alzheimer's disease.
- CAA is linked to significant brain changes and cognitive decline, highlighting its role in vascular dementia.
- Further research into CAA-specific pathways is crucial for understanding and treating age-related cognitive impairment.
Abstract:
Sporadic, age-related cerebral amyloid angiopathy (CAA) is most commonly recognized clinically as a cause of hemorrhagic stroke and transient focal neurological episodes in older persons. But a growing body of research in the last 5 years shows that the pathophysiology of CAA is much more complex than previously believed, leading to many different types of brain injury. CAA has now been linked with brain atrophy in regions remote from those directly affected by intracerebral hematomas, and with risk for progressive cognitive decline in the absence of new hemorrhagic strokes. Therefore, CAA is associated with features - brain atrophy and progressive cognitive decline - that are typically considered hallmarks of neurodegenerative disease. Although CAA is usually accompanied by some degree of Alzheimer's disease pathology, the profiles of cortical thinning and cognitive impairment do not fully overlap with those seen in Alzheimer's disease, suggesting that there are CAA-specific pathways of neurodegeneration. CAA-related brain ischemia may be an important mechanism that leads to brain injury, cortical disconnection, and cognitive impairment. This article is part of the Special Issue "Vascular Dementia".
Related Concept Videos
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
01:22Alzheimer's Disease: Treatment
01:15Parkinson's Disease: Overview